Dr. Andres E. Morales La Madrid has an extensive background in pediatric oncology with a range of specializations, including Pediatric Hematology & Oncology, Pediatric Neuro Oncology, and Stem Cell Transplantation in Pediatrics. He has contributed significantly to medical research with numerous publications and is currently leading several research projects, particularly in the area of immunotherapy for diffuse intrinsic pontine glioma.
Education
- Medicine Degree, Universidad Peruana Cayetano Heredia - 2002
- Pediatrics Specialization, Vall Hebron Hospital - 2007
- Sub Specialty in Oncology, Hematology, and Stem Cell Transplantation in Pediatrics, University of Chicago - 2012
- Sub Specialty in Pediatric Neuro Oncology, Harvard University - 2013
- Master in Hospital Management and Health Resources, University of Barcelona - 2018
Publications
- "Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single center" - EJC Paediatric Oncology, 2023
- "EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping" - iScience, 2023
- "Systematic review and practical example for 3D printing in surgical planning and training in pediatric endoscopic skull base surgery" - INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2023
Research Projects
- "GLIOMATCH_The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics" - Funded by the European Commission, 2024 - 2028
- Clinical trial on the safety and feasibility of cellular immunotherapy for patients with DIPG - Funded by Instituto de Salud Carlos III (ISCIII), 2024 - 2027
- Research group project on developmental tumors - Funded by Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca, 2022 - 2025